Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia (ODYSSEY COMBO I)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 316 participants.

Also called NCT01644175

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 316 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01644175
Other papers using this trial's data
  • Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated statin therapy: The ODYSSEY COMBO I study American heart journal, 2015-06 DOI, PubMed 26027630

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01644175. Randomized; quadruple masking; primary purpose treatment. Start 2012-07 (registry gives no type); primary completion 2014-04 (actual). Results posted on 2015-11-06.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia (ODYSSEY COMBO I)
Condition
Hypercholesterolemia
Intervention (Drug)
Placebo (for alirocumab)
Intervention (Drug)
Alirocumab
Intervention (Drug)
Lipid-Modifying Therapy (LMT)
Lead sponsor
Sanofi (class: industry)
Collaborator
Regeneron Pharmaceuticals (class: industry)

Record details

Record id
cardio:ct-nct01644175
Content hash
516b2a3e8245a9fccba354b114b25ba993dc3bf90dc08100a23d7375bd29fc2b